- Home
- PSNY vs PRCT Comparison
PSNY vs PRCT Comparison
Compare PSNY & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PSNY
- PRCT
- Stock Information
- Founded
- PSNY 2017
- PRCT 2009
- Country
- PSNY Sweden
- PRCT United States
- Employees
- PSNY N/A
- PRCT N/A
- Industry
- PSNY Auto Manufacturing
- PRCT Medical Specialities
- Sector
- PSNY Consumer Discretionary
- PRCT Health Care
- Exchange
- PSNY Nasdaq
- PRCT Nasdaq
- Market Cap
- PSNY 2.3B
- PRCT 2.2B
- IPO Year
- PSNY N/A
- PRCT 2021
- Fundamental
- Price
- PSNY $1.08
- PRCT $41.59
- Analyst Decision
- PSNY Hold
- PRCT Buy
- Analyst Count
- PSNY 5
- PRCT 8
- Target Price
- PSNY $1.26
- PRCT $75.57
- AVG Volume (30 Days)
- PSNY 2.7M
- PRCT 1.6M
- Earning Date
- PSNY 08-28-2025
- PRCT 08-06-2025
- Dividend Yield
- PSNY N/A
- PRCT N/A
- EPS Growth
- PSNY N/A
- PRCT N/A
- EPS
- PSNY N/A
- PRCT N/A
- Revenue
- PSNY $2,034,261,000.00
- PRCT $274,950,000.00
- Revenue This Year
- PSNY $58.19
- PRCT $47.51
- Revenue Next Year
- PSNY $113.55
- PRCT $31.69
- P/E Ratio
- PSNY N/A
- PRCT N/A
- Revenue Growth
- PSNY N/A
- PRCT 55.71
- 52 Week Low
- PSNY $0.72
- PRCT $37.12
- 52 Week High
- PSNY $1.94
- PRCT $103.81
- Technical
- Relative Strength Index (RSI)
- PSNY 51.86
- PRCT 31.84
- Support Level
- PSNY $1.02
- PRCT $37.32
- Resistance Level
- PSNY $1.08
- PRCT $40.86
- Average True Range (ATR)
- PSNY 0.03
- PRCT 2.64
- MACD
- PSNY 0.00
- PRCT -0.67
- Stochastic Oscillator
- PSNY 75.00
- PRCT 24.56
About PSNY Polestar Automotive Holding UK PLC ADS
Polestar Automotive Holding UK PLC operates as an electric vehicle manufacturer. It engages in designing products that are engineered to excite consumers and drive change. Polestar defines market standards in design, technology, and sustainability. Polestar was established as a premium electric car brand by Volvo Cars and Geely Holdings. Polestar has produced two electric performance cars, namely Polestar 1 and Polestar 2. Geographically, it derives a majority of revenue from the United Kingdom.
About PRCT PROCEPT BioRobotics Corporation
PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, which are image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.